this post was submitted on 02 Feb 2025
50 points (100.0% liked)

Science

13133 readers
2 users here now

Studies, research findings, and interesting tidbits from the ever-expanding scientific world.

Subcommunities on Beehaw:


Be sure to also check out these other Fediverse science communities:


This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.

founded 3 years ago
MODERATORS
 

Now, millions more people will soon have access to this painkiller — a drug called suzetrigine that works by selectively blocking sodium channels on pain-sensing nerve cells and delivers opioid-level pain suppression without the risks of addiction, sedation or overdose. On Thursday, the US Food and Drug Administration approved suzetrigine for short-term pain management, making it the first pain drug given a regulatory nod in more than 20 years that works through a brand-new mechanism.

"This is a big step forward," says Stephen Waxman, a neuroscientist at the Yale School of Medicine in New Haven, Connecticut.

"Anything we can add to the toolbox that will allow us to reduce opioid dependency is a significant positive," says Paul White, an anaesthesiologist at the Cedars-Sinai Medical Center in Los Angeles, California, who was involved in suzetrigine's development.

you are viewing a single comment's thread
view the rest of the comments
[–] LoganNineFingers@lemmy.ca 5 points 1 week ago

As someone in the middle of the show "Dopesick" I'll take a pass on this one for a bit